Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Intercept Pharmaceuticals (ICPT)

Intercept Pharmaceuticals (ICPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 603,031
  • Shares Outstanding, K 41,417
  • Annual Sales, $ 363,470 K
  • Annual Income, $ -91,430 K
  • 60-Month Beta 1.14
  • Price/Sales 1.68
  • Price/Cash Flow N/A
  • Price/Book 5.68
Trade ICPT with:

Options Overview Details

View History
  • Implied Volatility 77.95% ( +1.09%)
  • Historical Volatility 52.44%
  • IV Percentile 6%
  • IV Rank 5.33%
  • IV High 220.42% on 02/25/22
  • IV Low 69.92% on 11/25/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 513
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 32,722
  • Open Int (30-Day) 34,203

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.41
  • Number of Estimates 8
  • High Estimate 0.40
  • Low Estimate -1.12
  • Prior Year -1.23
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.80 +6.30%
on 10/31/22
16.76 -12.47%
on 11/14/22
+0.34 (+2.37%)
since 10/28/22
3-Month
12.69 +15.60%
on 10/19/22
19.20 -23.59%
on 09/20/22
-3.91 (-21.04%)
since 08/29/22
52-Week
10.81 +35.71%
on 06/16/22
21.25 -30.96%
on 08/19/22
-2.43 (-14.21%)
since 11/26/21

Most Recent Stories

More News
Komodo Health’s Real-World Evidence and Technology Platform Powers Two Real-World Analyses in Primary Biliary Cholangitis for Intercept Pharmaceuticals

Today, Komodo Health announced a collaboration with Intercept Pharmaceuticals (Nasdaq: ICPT), powering clinical research and new real-world evidence with Komodo’s platform. Intercept leveraged Komodo’s...

ICPT : 14.66 (+0.69%)
Intercept (ICPT) Q3 Earnings Miss, Sales Beat, View Raised

Intercept (ICPT) posts a wider loss in Q3 due to a loss on extinguishment of debt but beats on sales. Management increases annual sales guidance.

DVAX : 11.99 (+0.50%)
PBYI : 4.48 (+1.59%)
ICPT : 14.66 (+0.69%)
VKTX : 4.06 (+1.25%)
Why Intercept Pharmaceuticals Stock Is Soaring Today

Investors are cheering the drugmaker's Q3 update.

ICPT : 14.66 (+0.69%)
Intercept Pharmaceuticals (ICPT) Reports Q3 Loss, Tops Revenue Estimates

Intercept (ICPT) delivered earnings and revenue surprises of -159.49% and 2.62%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ICPT : 14.66 (+0.69%)
RETA : 38.43 (+0.60%)
Intercept: Q3 Earnings Snapshot

Intercept: Q3 Earnings Snapshot

ICPT : 14.66 (+0.69%)
Implied Volatility Surging for Intercept Pharmaceuticals (ICPT) Stock Options

Investors need to pay close attention to Intercept Pharmaceuticals (ICPT) stock based on the movements in the options market lately.

ICPT : 14.66 (+0.69%)
Biotech Stock Roundup: ICPT, KALV Down on Study Data, VIR Up on Contract Win & More

Regulatory and pipeline updates from ICPT and KALV are the key highlights from the biotech sector during the past week.

BMY : 78.50 (-0.81%)
EXEL : 16.69 (-0.60%)
ICPT : 14.66 (+0.69%)
KALV : 5.09 (+0.99%)
VIR : 27.77 (+3.04%)
Nike's Down, but These 2 Nasdaq Stocks Fell Even Further Friday

Poor earnings and a business setback were costly for these companies.

NKE : 106.17 (+1.15%)
COMP : 2.76 (+2.22%)
$NASX : 11,035.13 (-0.13%)
ICPT : 14.66 (+0.69%)
RCII : 22.69 (+0.35%)
Intercept (ICPT) Stock Gains 13% in 3 Months: Here's Why

Intercept (ICPT) gains 13% in the past three months on positive regulatory and pipeline updates.

ICPT : 14.66 (+0.69%)
VKTX : 4.06 (+1.25%)
BOLT : 1.3100 (+1.53%)
Regeneron (REGN)/ Alnylam Report Promising Data from NASH Study

Regeneron (REGN) and its partner Alnylam announce promising data from its ongoing phase I study evaluating ALN-HSD in healthy adults and NASH patients.

REGN : 728.82 (-1.71%)
ALNY : 211.34 (+1.02%)
ICPT : 14.66 (+0.69%)
IMCR : 59.99 (+1.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing novel therapeutics to treat chronic liver diseases to market. The company's focus is on treating orphan and more prevalent liver diseases with limited treatment options. The company received FDA approval for Ocaliva an...

See More

Key Turning Points

3rd Resistance Point 15.44
2nd Resistance Point 15.18
1st Resistance Point 14.87
Last Price 14.66
1st Support Level 14.30
2nd Support Level 14.04
3rd Support Level 13.73

See More

52-Week High 21.25
Fibonacci 61.8% 17.26
Fibonacci 50% 16.03
Fibonacci 38.2% 14.80
Last Price 14.66
52-Week Low 10.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar